Will pharmaceutical companies manufacturing the allopathic treatment of MERS, ‘Ribavirin,’ be able to take the advantage?

While continuous death of MERS (Middle East Respiratory Syndrome) patients has suddenly increased interested in the treatment, the industry is paying attention to the manufacturing pharmaceutical companies of Ribavirin which is used as its allopathic treatment.

According to the Ministry of Food and Drug Safety and the industry concerned, MERS treatments have not been developed yet in the domes...